Riskpilot← Back to searchSign inGet full accessLivero Läkarmottagning AB
ABActiveOrg 5566754155Other human health activities n.e.c. · NACE 8699Est. 20050 employees
Revenue 2025
—
EBITDA margin
—
-20% vs 2024
Equity ratio
93.2%
Financial strength
Net profit 2025
SEK 4,4M
+243% vs 2024
| Revenue | — | — |
| EBITDA | SEK -13K | -20% |
| Net profit | SEK 4,4M | +243% |
| Total assets | SEK 4,9M | +11% |
| Equity | SEK 4,6M | +13% |
| Employees | 0 | — |
Legal name
Livero Läkarmottagning AB
Org number
5566754155
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
27 januari 2005
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Föremålet för bolagets verksamhet är att bedriva medicinska konsultationer och utbildning inom detta område samt därmed förenlig verksamhet.
Address
Phone
+4686795900
Email
info@bolagspartner.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −2 | −7 | −9 | −11 | −13 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −2 | −7 | −9 | −11 | −13 |
| Net financials | — | 0 | 1 | 1 301 | 4 446 |
| Profit before tax | −2 | −7 | −8 | 1 291 | 4 433 |
| Tax | −0 | — | — | — | — |
| Net profit | −2 | −7 | −8 | 1 291 | 4 433 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 979 | 4 979 | 4 588 | 4 450 | 4 936 |
| Equity | 4 775 | 4 580 | 4 378 | 4 068 | 4 601 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 204 | 398 | 210 | 382 | 335 |
| Total debt | 204 | 398 | 210 | 382 | 335 |
EBITDA margin
-1294500.0%
This company
15.8%
Market median
-8193138% vs market
20212025
Equity ratio
93.2%
This company
38.2%
Market median
+144% vs market
20212025
Return on equity
96.3%
This company
18.4%
Market median
+423% vs market
20212025
Net profit margin
443272100.0%
This company
8.1%
Market median
+5472494962% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2026 | |
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2026 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Livero Läkarmottagning AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Anna Maria Johansson Berg | Deputy Board Member | 0 companies |
| Karl-Johan Staffan Tångby | Board of Directors | 0 companies |
| Ann-Marie Kerstin Dellner | Deputy Board Member | 0 companies |
| Erling Vabö | Board of Directors | 0 companies |